TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
1,061
|
790
|
1,252 |
| Financial expenses |
56
|
110
|
440 |
| Earnings before taxes |
342
|
-115
|
97 |
| EBITDA |
393
|
-16
|
537 |
| Total assets |
15,374
|
14,601
|
14,903 |
| Current assets |
783
|
768
|
1,152 |
| Current liabilities |
160
|
257
|
386 |
| Equity capital |
15,148
|
14,278
|
14,408 |
| - share capital |
106
|
100
|
99 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
98.5%
|
97.8%
|
96.7% |
| Turnover per employee |
1,061
|
790
|
1,252 |
| Profit as a percentage of turnover |
32.2%
|
-14.6%
|
7.7% |
| Return on assets (ROA) |
2.6%
|
0.0%
|
3.6% |
| Current ratio |
489.4%
|
298.8%
|
298.4% |
| Return on equity (ROE) |
2.3%
|
-0.8%
|
0.7% |
| Change turnover |
225
|
-479
|
479 |
| Change turnover % |
27%
|
-38%
|
62% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.